A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology

Thorax

Volumn 62, Issue 3, 2007, Pages 242-247

  Gosman, Margot M E ^a   Boezen, H Marike ^a   Van Diemen, Cleo C ^a   Snoeck Stroband, Jiska B ^b   Lapperre, Thérèse S ^b   Hiemstra, Pieter S ^b   Ten Hacken, Nick H T ^a   Stolk, Jan ^a,b   Postma, Dirkje S ^a   Kauffman, H F ^a   De Reus, D ^a   Jansen, D F ^a   Vonk, J M ^a   Barentsen, M D W ^a   Luinge, M ^a   Timens, W ^a   Zeinstra Smit, M ^a   Luteijn, A J ^a   Van Der Molen, T ^a   Ter Veen, G ^a   Farenhorst, M P ^a   Kerstjens, H A M ^a   Van Maaren, M S ^a   Veltman, C A ^a   Verbokkem, A ^a   Verhage, I ^a   Vink Klooster, H K ^a   Snoeck Stroband, J B ^b   Thiadens, H ^b   Sont, J K ^b   Bajema, I ^b   Gast Strookman, J ^b   Hjemstra, P S ^b   Janssen, K ^b   Rabe, K F ^b   Van Schadewijk, A ^b   Smit Bakker, J ^b   Sterk, P J ^b   Tiré, Acja ^b   Van Der Veen, H ^b   Wijffels, M M E ^b   Willems, L N A ^b   Mauad, T ^c   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; DNA; METHACHOLINE; PROTEIN ADAM33; UNCLASSIFIED DRUG; ADAM33 PROTEIN, HUMAN;

ADULT; ARTICLE; BRONCHUS BIOPSY; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA DETERMINATION; DNA POLYMORPHISM; FORCED EXPIRATORY VOLUME; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL; PATHOPHYSIOLOGY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPUTUM ANALYSIS; ANALYSIS OF VARIANCE; BIOPSY; BRONCHITIS; BRONCHUS; BRONCHUS HYPERREACTIVITY; CYTOLOGY; EOSINOPHIL; FEMALE; GENETICS; MAST CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; SPUTUM;

ADAM PROTEINS; ANALYSIS OF VARIANCE; BIOPSY; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHITIS; EOSINOPHILS; FEMALE; HUMANS; MALE; MAST CELLS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 33947596912     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.060988     Document Type: Article

References (33)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
2. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
3. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1304-9.
4. Tashkin DP, Altose MD, Bleecker ER, et al. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 1992;145:301-10.
5. Finkelstein R, Ma HD, Ghezzo H, et al. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. Am J Respir Crit Care Med 1995;152:267-76.
6. Mullen JB, Wiggs BR, Wright JL, et al. Nonspecific airway reactivity in cigarette smokers. Relationship to airway pathology and baseline lung function. Am Rev Respir Dis 1986;133:120-5.
7. Rutgers SR, Timens W, Tzanakis N, et al. Airway inflammation and hyperresponsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease. Clin Exp Allergy 2000;30:657-62.
8. Willemse BW, ten Hacken NM, Rutgers B, et al. Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD. Eur Respir J 2004;24:391-6.
9. Van Eerdewegh P, Little RD, Dupuis J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002;418:426-30.
10. Blakey J, Halapi E, Bjornsdottir US, et al. Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax 2005;60:274-6.
11. van Diemen CC, Postma DS, Vonk JM, et al. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005;172:329-33.
12. Jongepier H, Boezen HM, Dijkstra A, et al. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 2004;34:757-60.
13. Black RA, White JM. ADAMs: focus on the protease domain. Curr Opin Cell Biol 1998;10:654-9.
14. Primakoff P, Myles DG. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 2000;16:83-7.
15. Garlisi CG, Zou J, Devito KE, et al. Human ADAM33: protein maturation and localization. Biochem Biophys Res Commun 2003;301:35-43.
16. Zou J, Zhu F, Liu J, et al. Catalytic activity of human ADAM33. J Biol Chem 2004;279:9818-30.
17. Davies DE, Wicks J, Powell RM, et al. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003;111:215-25.
18. Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:499-504.
19. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:53-83.
20. in't Veen JC, de Gouw HW, Smits HH, et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996;9:2441-7.
21. Lapperre TS, Postma DS, Gosman MM, et al. Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax 2006;61:115-21.
22. Howard TD, Postma DS, Jongepier H, et al. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J Allergy Clin Immunol 2003;112:717-22.
23. Werner M, Herbon N, Gohlke H, et al. Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin Exp Allergy 2004;34:26-31.
24. Umland SP, Garlisi CG, Shah H, et al. Human ADAM33 messenger RNA expression profile and post-transcriptional regulation. Am J Respir Cell Mol Biol 2003;29:571-82.
25. Tashkin DP, Altose MD, Connett JE, et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996;153:1802-11.
26. Hospers JJ, Postma DS, Rijcken B, et al. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000;356:1313-17.
27. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998;53:953-6.
28. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-4.
29. Ronchi MC, Piragino C, Rosi E, et al. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996;51:1000-4.
30. Gosman MME, van der Meulen J. M, Lapperre TS, et al. Airway hyperresponsiveness in COPD is more severe in females, patients with lower FEV1/VC, and higher total cell numbers in sputum. Am J Respir Crit Care Med 2004;167:A86.
31. O'Shaughnessy TC, Ansari TW, Barnes NC, et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997;155:852-7.
32. Lind DL, Choudhry S, Ung N, et al. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am J Respir Crit Care Med 2003;168:1312-16.
33. Raby BA, Silverman EK, Kwiatkowski DJ, et al. ADAM33 polymorphisms and phenotype associations in childhood asthma. J Allergy Clin Immunol 2004;113:1071-8.